The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

Antibiotics once turned deadly infections into curable ones. That trust is now cracking. Across hospitals and homes, germs ...

A DRUG resistant form of killer fungus is rapidly spreading across the globe and becoming more infectious, scientists warn.

Gynecologists long viewed bacterial vaginosis as solely a women’s issue — until a study that treated their male partners, too ...

The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035[1], driven by a fundamental shift in cancer treatment philosophy. Biomarker-guided therapy ...

Two newly approved oral antibiotics offer hope against drug-resistant gonorrhea after decades without new treatments, as ...

Amoxicillin, a commonly prescribed antibiotic, can cause skin rashes in 5–10 per cent of children. These range from mild non ...

All of this disproportionately affects the elderly. In a 2023 study of patients with a median age of 75, approximately 30% of ...

Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...

This month, the U.S. Food and Drug Administration cleared two new oral antibiotics for use against gonorrhea: zoliflodacin ...

Urinary incontinence (UI) is the involuntary loss of urine. Just having a UI “accident” occasionally may not require ...